FDA Expands Recall of SUPPLX.com Supplements Over Undeclared Yohimbine
The recall of two male enhancement supplements has been expanded; consumers are urged to stop use and dispose of remaining product.
4 reports on this incident · first at Sep 6, 2026, 1:25 p.m. ET
Earlier reports
Sep 6, 2026, 2:23 p.m. ET
FDA Reports Illnesses Linked to SUPPLX.com Supplements Recalled Over Undeclared Yohimbine
The U.S. Food and Drug Administration has received reports of injuries or illnesses associated with two male sexual enhancement supplements recalled by SUPPLX.com, according to Medical Daily. The agency did not specify the number or nature of the reports.
The recall, which remains ongoing, covers products sold under the brand names Business Pill and Branch Manager for Men. The supplements were packaged in single-capsule blister cards and sold in 24-count retail boxes nationwide.
FDA laboratory analysis confirmed that both products contain yohimbine at levels the agency called dangerously high, and that the ingredient does not appear on the labels, Medical Daily reported. Yohimbine can cause severe hypertension, rapid heart rate, and possibly cardiac arrhythmia and heart attack. The recall notice did not cite any illness reports at the time of its issuance.
The agency advises consumers to stop using the products immediately and dispose of any remaining supply.
Sep 6, 2026, 1:52 p.m. ET
FDA Closes Recall of SUPPLX.com Supplements Over Undeclared Yohimbine
The U.S. Food and Drug Administration has closed the recall of two male sexual enhancement supplements distributed nationwide by SUPPLX.com, according to a report from Medical Daily. The agency considers the recall carried out, meaning consumers who still have the products should stop using them and dispose of any remaining supply.
The recalled products are Business Pill and Branch Manager for Men, sold in 24-count retail boxes containing single capsule blister cards. FDA laboratory analysis confirmed that both contain yohimbine at levels the agency called dangerously high, and that the ingredient does not appear on the labels. Yohimbine can cause severe hypertension, rapid heart rate, and possibly cardiac arrhythmia and heart attack. No illness reports were cited in the recall notice.
The recall remains ongoing, and consumers are advised to check their supplies for these products and follow the disposal instructions.
Sep 6, 2026, 1:25 p.m. ETFirst report
SUPPLX.com Recalls Two Male Enhancement Supplements Over Undeclared Yohimbine
SUPPLX.com is recalling two male sexual enhancement supplements sold nationwide, according to a notice reported by Medical Daily. The products, Business Pill and Branch Manager for Men, were packaged in single capsule blister cards and sold in 24-count retail boxes.
The recall was prompted by FDA laboratory analysis confirming that both products contain yohimbine at levels the agency called dangerously high, and that the ingredient does not appear anywhere on the labels. Yohimbine can cause severe hypertension, rapid heart rate, and possibly cardiac arrhythmia and heart attack. No illness reports were cited in the recall notice.
The company advises consumers to stop using the products immediately and dispose of any remaining supply. The recall is ongoing.
Was this report accurate and useful?
Sources
Revision history
- Version 16 Sept 2026, 18:52current
First published.
- Version 16 Sept 2026, 17:25current
First published.
- Version 16 Sept 2026, 18:23current
First published.
- Version 16 Sept 2026, 17:52current
First published.
How we work
This site models an investigative reporter rather than a wire desk. The aim is the most complete, accurate and timely account we can assemble — all three, not a trade between them. Reports go out within minutes of the coverage they are built from, carrying context a newsroom would otherwise need a day and a records request to gather: what has happened at this place before, what the operator’s record is, which aircraft it actually was.
Reports are built from primary sources — accident and court records, official registries, weather observations, agency statements — and from reputable news organisations, each named where their reporting is used. Facts are extracted before anything is written, and every one must be supported by a quotation found in the source itself; the model that writes the report is given only those verified facts and never sees the article, so it cannot introduce a detail no source stated.
Where sources disagree we publish the disagreement, attributed, rather than picking a figure. Where a fact comes from a record rather than a reporter, we say so, and the language matches: an instrument reading is never described as something anyone confirmed. Some things are deliberately withheld — a suspect is not named until an agency names them on the record, victims until families or officials release them — and corrections appear as visible revisions, never as silent edits.
None of that makes a report true. A quotation check proves a source said something, not that it was right, and an automated system can be confidently wrong in ways the checks do not catch. If something here is wrong, the feedback above is how it gets found. The full methodology, including what we refuse to publish.